Company intelligence / Profile preview

Cendo

Bandung, West Java, Indonesia

Ownership: Private
Employees: ~500
Development stage: Other

Overview

PT Cendo Pharmaceutical Industries, commonly known as Cendo, is a leading Indonesian pharmaceutical company specializing in the development and manufacture of ophthalmic products. Established in 1970 and headquartered in Bandung, the company produces a wide range of eye care treatments, including eye drops, ointments, and surgical supplies. Cendo is recognized for its extensive portfolio of over 100 products and its adherence to Good Manufacturing Practices (GMP). The company serves both the domestic Indonesian market and international markets, maintaining a dominant position in the Southeast Asian eye care sector.

Therapeutic areas: OphthalmologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Cendo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cendo.

Explore the full profile